Literature DB >> 19477666

A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly.

Siddharth Shah1, Yadlapalli Kumar, Brendan McLean, Amanda Churchill, Neil Stoodley, Julia Rankin, Patrizia Rizzu, Marjo van der Knaap, Philip Jardine.   

Abstract

We describe a three generation family with recurrent strokes and cataracts. The index case, a 14 year old boy presented with stroke at the age of 14 years and again 6 months later. His mother had long standing episodic headaches diagnosed as migraine. Grandmother was initially diagnosed with multiple sclerosis and had recurrent strokes at age 18 years and 49 years. MRI scanning showed a diffuse leukoencephalopathy with microhaemorrhages in all three individuals. All of the family members had cataracts but did not have retinal arterial changes. Sequence analysis of COL4A1 revealed the heterozygous missense mutation c.2263G-->A in exon 30, responsible for a glycine-to-arginine substitution (p.Gly755Arg) in both the index case and mother. Grandmother died at the age of 73 years and DNA analysis was not possible. Mutation in COL4A1 should be considered in families with a history of autosomal dominant cerebral vasculopathy, even in the absence of porencephaly. 2009 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477666     DOI: 10.1016/j.ejpn.2009.04.010

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  24 in total

1.  Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Hairong Dong; Mila Blaivas; Michael M Wang
Journal:  Brain Res       Date:  2012-03-23       Impact factor: 3.252

2.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

Review 3.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

4.  Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods.

Authors:  Phanichand Kodali; Karnakar R Chitta; Julio A Landero Figueroa; Joseph A Caruso; Opeolu Adeoye
Journal:  Metallomics       Date:  2012-09-14       Impact factor: 4.526

5.  COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke.

Authors:  Marion Jeanne; Cassandre Labelle-Dumais; Jeff Jorgensen; W Berkeley Kauffman; Grazia M Mancini; Jack Favor; Valerie Valant; Steven M Greenberg; Jonathan Rosand; Douglas B Gould
Journal:  Am J Hum Genet       Date:  2011-12-29       Impact factor: 11.025

6.  COL4A1 mutations should not be a contraindication for epilepsy surgery.

Authors:  Apostolos Papandreou; Martin M Tisdall; W K Chong; J Helen Cross; William F Harkness; Sophia M Varadkar
Journal:  Childs Nerv Syst       Date:  2014-05-27       Impact factor: 1.475

7.  COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.

Authors:  Cassandre Labelle-Dumais; Vera Schuitema; Genki Hayashi; Kendall Hoff; Wenhui Gong; Dang Q Dao; Erik M Ullian; Peter Oishi; Marta Margeta; Douglas B Gould
Journal:  Am J Hum Genet       Date:  2019-05-02       Impact factor: 11.025

Review 8.  Lens capsule as a model to study type IV collagen.

Authors:  Christopher F Cummings; Billy G Hudson
Journal:  Connect Tissue Res       Date:  2014 Jan-Feb       Impact factor: 3.417

9.  Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency.

Authors:  Robin Lemmens; Alessandra Maugeri; Hans W M Niessen; An Goris; Thomas Tousseyn; Philippe Demaerel; Anniek Corveleyn; Wim Robberecht; Marjo S van der Knaap; Vincent N Thijs; Petra J G Zwijnenburg
Journal:  Hum Mol Genet       Date:  2012-10-12       Impact factor: 6.150

10.  Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.

Authors:  S Alamowitch; E Plaisier; P Favrole; C Prost; Z Chen; T Van Agtmael; B Marro; P Ronco
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.